NCT01836029 2019-10-29Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCelgenePhase 2 Completed195 enrolled 13 charts
NCT01289210 2019-09-25VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell LymphomasCelgenePhase 1/2 Terminated2 enrolled 4 charts